[Form 4] L3HARRIS TECHNOLOGIES, INC. /DE/ Insider Trading Activity

Rhea-AI Filing Summary

L3Harris Technologies (LHX) Chair and CEO Christopher E. Kubasik reported insider transactions. On 11/13/2025, he exercised 14,171 non‑qualified stock options at $162.30 per share (code M) and sold 14,171 shares at $301.05 (code S) pursuant to a Rule 10b5‑1(c) plan adopted on June 13, 2025.

Following these transactions, he directly owned 144,426 shares and held 30,000 shares indirectly via a grantor retained annuity trust. A separate transaction (code I) disposed of 1,156.37 shares held through the issuer’s retirement plan at $288.37, leaving 0 shares via the plan. The footnote notes plan-based adjustments of 1,151.82 shares excluded and 4.56 shares acquired as of 11/13/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KUBASIK CHRISTOPHER E

(Last) (First) (Middle)

C/O L3HARRIS TECHNOLOGIES, INC.

1025 W. NASA BOULEVARD

(Street)

MELBOURNE FL 32919

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
L3HARRIS TECHNOLOGIES, INC. /DE/ [ LHX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair and CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, Par Value $1.00	11/13/2025		M		14,171	A	$162.3	158,597(1)	D
Common Stock, Par Value $1.00	11/13/2025		S(2)		14,171	D	$301.05	144,426	D
Common Stock, Par Value $1.00	11/13/2025		I		1,156.37	D	$288.37	0	I	By retirement plan
Common Stock, Par Value $1.00								30,000	I	By grantor retained annuity trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy)	$162.3	11/13/2025		M			14,171	06/29/2019	02/20/2028	Common Stock, Par Value $1.00	14,171	$0	0	D

Explanation of Responses:

1. Excludes 1,151.82 shares held by the Issuer's retirement plan (the "Plan) previously reported as directly owned, and 4.56 shares acquired through the Plan based on information provided by the Plan's administrators as of 11/13/2025.

2. Pursuant to written plan intended to satisfy Rule 10b5-1(c), adopted by the reporting person on June 13, 2025.

Remarks:

	By: /s/ John C. Scarborough, Jr., Attorney-in-Fact For: Christopher E. Kubasik	11/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did LHX report?

The CEO exercised 14,171 stock options at $162.30 (code M) and sold 14,171 shares at $301.05 (code S) on 11/13/2025.

Was the LHX CEO’s sale under a 10b5-1 plan?

Yes. The sale was pursuant to a written plan intended to satisfy Rule 10b5‑1(c), adopted on June 13, 2025.

How many LHX shares does the CEO hold after the transactions?

He held 144,426 shares directly and 30,000 shares indirectly via a grantor retained annuity trust.

Were there retirement plan share changes for LHX’s CEO?

Yes. A code I transaction disposed of 1,156.37 shares at $288.37, leaving 0 shares via the plan.

What do the Form 4 footnotes disclose for LHX?

They state 1,151.82 plan shares were excluded from direct ownership and 4.56 shares were acquired through the plan as of 11/13/2025.

What type of derivative security was exercised?

A non‑qualified stock option (right to buy) for 14,171 shares with a $162.30 exercise price.